IL234116B - A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system - Google Patents
A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune systemInfo
- Publication number
- IL234116B IL234116B IL234116A IL23411614A IL234116B IL 234116 B IL234116 B IL 234116B IL 234116 A IL234116 A IL 234116A IL 23411614 A IL23411614 A IL 23411614A IL 234116 B IL234116 B IL 234116B
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- composition
- parainfluenza virus
- sialidase activity
- immunocomprimised
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600545P | 2012-02-17 | 2012-02-17 | |
| US201261727627P | 2012-11-16 | 2012-11-16 | |
| PCT/US2013/026754 WO2013123521A1 (en) | 2012-02-17 | 2013-02-19 | Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL234116B true IL234116B (en) | 2020-03-31 |
Family
ID=48984833
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL234116A IL234116B (en) | 2012-02-17 | 2014-08-13 | A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system |
| IL273194A IL273194B2 (en) | 2012-02-17 | 2020-03-10 | Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL273194A IL273194B2 (en) | 2012-02-17 | 2020-03-10 | Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US20130280332A1 (enExample) |
| EP (1) | EP2841092B1 (enExample) |
| JP (1) | JP2015508780A (enExample) |
| CN (2) | CN109529026A (enExample) |
| AU (3) | AU2013221230A1 (enExample) |
| CA (1) | CA2864746A1 (enExample) |
| ES (1) | ES2970401T3 (enExample) |
| IL (2) | IL234116B (enExample) |
| WO (1) | WO2013123521A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2571503T3 (pl) | 2010-05-14 | 2015-06-30 | Dana Farber Cancer Inst Inc | Kompozycje i sposoby leczenia nowotworu, choroby zapalnej i innych zaburzeń |
| CA2799403C (en) | 2010-05-14 | 2020-01-21 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating leukemia |
| EP2571875A4 (en) | 2010-05-14 | 2013-10-30 | Dana Farber Cancer Inst Inc | CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF |
| WO2015013635A2 (en) | 2013-07-25 | 2015-01-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
| WO2015070020A2 (en) | 2013-11-08 | 2015-05-14 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors |
| KR20160115953A (ko) | 2014-01-31 | 2016-10-06 | 다나-파버 캔서 인스티튜트 인크. | 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도 |
| WO2015117087A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| CN106456653A (zh) | 2014-02-28 | 2017-02-22 | 腾沙治疗公司 | 高胰岛素血症相关病症的治疗 |
| WO2016022902A1 (en) | 2014-08-08 | 2016-02-11 | Dana-Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| CA2955077A1 (en) | 2014-08-08 | 2016-02-11 | Dana-Farber Cancer Institute, Inc. | Dihydropteridinone derivatives and uses thereof |
| MX376748B (es) | 2014-10-27 | 2025-03-07 | Tensha Therapeutics Inc | Inhibidores del bromodominio. |
| CN107249593A (zh) * | 2014-11-06 | 2017-10-13 | 达纳-法伯癌症研究所股份有限公司 | 调节染色质结构的组合物用于移植物抗宿主疾病(gvhd)的用途 |
| KR20170081213A (ko) | 2014-11-06 | 2017-07-11 | 다나-파버 캔서 인스티튜트 인크. | Ezh2 억제제 및 그의 용도 |
| WO2016200916A1 (en) * | 2015-06-08 | 2016-12-15 | Ansun Biopharma, Inc. | Treatment of human metapneumovirus |
| WO2016201370A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| JP2018526424A (ja) | 2015-09-11 | 2018-09-13 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | アセトアミドチエノトリアゾロジアゼピンおよびこれらの使用 |
| KR20180049058A (ko) | 2015-09-11 | 2018-05-10 | 다나-파버 캔서 인스티튜트 인크. | 시아노 티에노트리아졸로디아제핀 및 그의 용도 |
| CN114957291A (zh) | 2015-11-25 | 2022-08-30 | 达纳-法伯癌症研究所股份有限公司 | 二价溴结构域抑制剂及其用途 |
| JP7493304B2 (ja) | 2016-04-22 | 2024-05-31 | ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド | Ｅｚｈ２インヒビターおよびそれらの使用 |
| US20230330140A1 (en) * | 2019-11-25 | 2023-10-19 | Ansun Biopharma, Inc. | Immune cell delivery of sialidase cancer cells, immune cells and the tumor microenvironment |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7334580B2 (en) * | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
| CA2497845C (en) * | 2002-09-06 | 2012-08-14 | Chrysalis Technologies Incorporated | Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| CA2506526C (en) | 2002-11-22 | 2017-04-18 | Mang Yu | Broad spectrum anti-viral therapeutics and prophylaxis |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| CA2639925C (en) * | 2006-01-24 | 2016-07-12 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
| WO2011057081A1 (en) * | 2009-11-06 | 2011-05-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
-
2013
- 2013-02-19 ES ES13749329T patent/ES2970401T3/es active Active
- 2013-02-19 AU AU2013221230A patent/AU2013221230A1/en not_active Abandoned
- 2013-02-19 WO PCT/US2013/026754 patent/WO2013123521A1/en not_active Ceased
- 2013-02-19 US US13/770,991 patent/US20130280332A1/en not_active Abandoned
- 2013-02-19 CN CN201811368987.7A patent/CN109529026A/zh active Pending
- 2013-02-19 EP EP13749329.2A patent/EP2841092B1/en active Active
- 2013-02-19 JP JP2014557870A patent/JP2015508780A/ja active Pending
- 2013-02-19 CN CN201380009763.6A patent/CN104203267A/zh active Pending
- 2013-02-19 CA CA2864746A patent/CA2864746A1/en not_active Abandoned
-
2014
- 2014-08-13 IL IL234116A patent/IL234116B/en active IP Right Grant
-
2015
- 2015-01-26 US US14/605,572 patent/US20150132274A1/en not_active Abandoned
-
2017
- 2017-02-10 US US15/430,288 patent/US20170151315A1/en not_active Abandoned
- 2017-11-10 AU AU2017258955A patent/AU2017258955A1/en not_active Abandoned
-
2019
- 2019-09-05 AU AU2019226190A patent/AU2019226190B2/en not_active Ceased
-
2020
- 2020-03-10 IL IL273194A patent/IL273194B2/en unknown
- 2020-07-31 US US16/945,776 patent/US20210046165A1/en not_active Abandoned
-
2025
- 2025-01-21 US US19/033,237 patent/US20250387457A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015508780A (ja) | 2015-03-23 |
| EP2841092C0 (en) | 2023-12-06 |
| IL273194A (en) | 2020-04-30 |
| US20210046165A1 (en) | 2021-02-18 |
| WO2013123521A1 (en) | 2013-08-22 |
| CA2864746A1 (en) | 2013-08-22 |
| AU2013221230A1 (en) | 2014-10-02 |
| HK1207975A1 (en) | 2016-02-19 |
| US20150132274A1 (en) | 2015-05-14 |
| AU2019226190B2 (en) | 2021-10-07 |
| CN104203267A (zh) | 2014-12-10 |
| US20130280332A1 (en) | 2013-10-24 |
| AU2019226190A1 (en) | 2019-09-26 |
| EP2841092A4 (en) | 2015-09-16 |
| CN109529026A (zh) | 2019-03-29 |
| US20250387457A1 (en) | 2025-12-25 |
| ES2970401T3 (es) | 2024-05-28 |
| AU2017258955A1 (en) | 2017-12-14 |
| US20170151315A1 (en) | 2017-06-01 |
| IL273194B (en) | 2022-10-01 |
| EP2841092B1 (en) | 2023-12-06 |
| EP2841092A1 (en) | 2015-03-04 |
| IL273194B2 (en) | 2023-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL234116B (en) | A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system | |
| IL249991A0 (en) | Methods of treating sick children by dexmedetomidine | |
| ZA201308417B (en) | Tissue healing | |
| IL234678A0 (en) | Diagnostic methods and preparations for cancer treatment | |
| IL237568A0 (en) | Assembly for the treatment of biological tissues | |
| GB201202773D0 (en) | Compositions for treatment of skin disorders | |
| HUE038787T2 (hu) | Tripeptid készítmények és alkalmazásuk diabétesz kezelésére | |
| EP2797593A4 (en) | SILICONE-BASED COMPOSITION FOR TREATING SKIN | |
| IL234606A0 (en) | Innovative methods and compounds for the treatment of diseases | |
| IL232434A0 (en) | Medicine for medical treatment and/or improvement of sepsis | |
| EP2872087A4 (en) | IMPROVED NON-SKINLESSING DISPOSABLE THREAD | |
| GB201102248D0 (en) | Treatment of bipolar disorder | |
| ZA201307058B (en) | Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
| SG11201504201RA (en) | Purification of x-ray contrast agents | |
| ZA201409502B (en) | Composition for treatment of warts | |
| GB201010638D0 (en) | Composition for treatment of skin | |
| PL2456445T3 (pl) | Środek do leczenia chorób skóry | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| GB201110653D0 (en) | Composition for skin treatment | |
| GB201110659D0 (en) | composition for skin treatment | |
| GB201208505D0 (en) | Treatment of skin condition | |
| EP2854878A4 (en) | MEDICAL DEVICE FOR TREATING WOUNDS | |
| GB201121044D0 (en) | Treatment of solutions | |
| GB201104632D0 (en) | Use of medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |